IMS Health is the world’s leading provider of market intelligence to the pharmaceutical and healthcare industries. With $2.3 billion in 2008 revenue and more than 50 years of industry experience, IMS offers leading-edge market intelligence products and services that are integral to clients’ day-to-day operations, including product and portfolio management capabilities; commercial effectiveness innovations; managed care and consumer health offerings; and consulting and services solutions that improve productivity and the delivery of quality healthcare worldwide.

Recent Milestones
edit

IMS Health acquired Semantelli. (4/30/13)

Posted 4/30/13 at 7:00am via imshealth.com
IMS Health acquired Appature. (3/12/13)

Posted 3/12/13 at 7:24pm via imshealth.com
IMS Health — IMS Health to be Acquired by TPG and CPP Investment Board. (11/5/09)

Posted 1/22/10 at 9:49pm via imshealth.com
IMS Health added Andree Coude as MDX Product Manager. (6/1/02)

Posted 6/7/13 at 3:45am
IMS Health added Anthony Boone as Director, Communications. (1/1/92)

Posted 5/23/13 at 11:34pm
IMS Health added James Han as Consultant: Marketing Researcher.

Posted 3/24/13 at 8:52pm
IMS Health added Ari Bousbib as Chairman & CEO.

Posted 3/12/13 at 7:10pm
IMS Health added Ronald Bruehlman as SVP & CFO.

Posted 3/12/13 at 7:10pm